The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | Introducing the MyMPNVoice app: a patient support tool and research study
In this video, Patrick Harrington, MRCP, FRCPath, PhD, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK, introduces the new MyMPNVoice app designed to support patients with myeloproliferative neoplasms (MPNs). The recently launched app helps patients track their symptoms over time and will allow for the impact of treatment on symptom burden to be studied. In a cohort of these patients, biometric data from wearable devices will be integrated, and any associations with symptom scores will be identified. This unique patient support tool and research study aim to collect high-quality data to further current knowledge in MPNs. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
